Acta Médica Peruana
ISSN 1728-5917 versión on-line
PEREZ GALDOS, Proel. Costo médico directo de la epilepsia en la población hospitalaria del Hospital III Miguel Grau de EsSalud. Acta méd. peruana, ene./mar. 2010, vol.27, no.1, p.37-42. ISSN 1728-5917.
Objectives: To determine direct costs of epilepsy in a population assigned to one hospital in Peruvian Social Security (EsSalud) during year 2006. To point out which group of epileptic patients generate more direct costs. Methodology: A retrospective study including 462 epilepsy patients was performed in order to estimate medical direct costs, considering the Sales Value = Retail price - 19% (Peruvian added value tax), obtained from the EsSalud rate lists; as well as prices for antiepileptic drugs (AED) (generics), which are the lowest within Peru. Descriptive and analytic statistics were used, as well as Chi square and Student’s t tests. Results: Fifty three per cent patients were male, and their average age was 40.7 years (± 22.03 SD); 95.7% of epileptic episodes were generalized crises, 17.7% were refractory, the average number of hospital visits was 6.26 (± 3.16 SD), 9.1% patients were hospitalized, and the average hospital stay was 6.93 days (± 4.72 SD). Annual direct costs were 71,433.24 US Dollars, average direct costs for controlled epilepsy were USD 118.5 and for refractory epilepsy, the amount was 321.9 USD (p<0.0001). Conclusion: Costs for specialized consultations (37%) and AEDs (34%) represented the greatest annual expenses, and the direct average cost was 154.61 USD/patient/year. Average costs for refractory epilepsy were three times higher than those for controlled epilepsy; and direct costs reported in this study are quite lower than those reported in industrialized countries and even in neighboring countries.
Palabras llave: Costs and cost analysis; epilepsy; epileptic.
Colegio Médico del Perú
Malecón Armendariz 791, Miraflores
Lima 18 - Perú
Teléfono : (511) 705-1400
Fax : (511) 705- 1412